Psychiatry & Behavioral Health

Alcohol Use Disorder

Alcohol Use Disorder (AUD) is a chronic medical condition that affects millions of individuals and families across the United States. CenExel supports innovative clinical research focused on improving treatment outcomes, reducing relapse risk, and advancing evidence-based therapies for adults living with alcohol dependence and co-occurring behavioral health conditions.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Alcohol Use Disorder Clinical Research

CenExel delivers specialized scientific and operational expertise for Alcohol Use Disorder clinical trials. Our experienced behavioral health research teams support sponsors with patient recruitment, treatment evaluation, biomarker strategies, and regulatory-focused execution from early phase through post-market studies.

Optimize Participant Retention

Experienced site teams and participant-focused engagement strategies help improve participant compliance and long-term retention.

Accelerate Study Outcomes

Integrated operational workflows and experienced investigators support faster enrollment and efficient study execution.
Conditions Covered

Alcohol Use Disorder Research Areas

CenExel supports a broad range of Alcohol Use Disorder and addiction-related clinical research programs.

  • Alcohol Dependence
  • Alcohol Withdrawal Syndrome
  • Relapse Prevention
  • Craving Reduction
  • Co-Occurring Anxiety Disorders
  • Depression & AUD
  • Substance Use Disorders
  • Dual Diagnosis Conditions
Our Approach

Why Sponsors Choose CenExel for Alcohol Use Disorder Studies

CenExel combines deep behavioral health expertise with scalable recruitment strategies and experienced clinical operations teams to support Alcohol Use Disorder research programs nationwide.

01

Addiction Research Expertise

Dedicated behavioral health investigators with extensive experience in addiction medicine and substance use disorder trials.

02

Diverse Patient Recruitment

Access to broad participant populations across multiple regions improves enrollment diversity and study representation.

03

Biomarker & Outcome Strategiesx

Support for advanced endpoints, participant-reported outcomes, and relapse monitoring methodologies.

04

High Retention Rates

Participant engagement programs designed to reduce dropout rates and improve long-term participation.

Phase Coverage

Supported Alcohol Use Disorder Trial Phases

CenExel supports early and late phase Alcohol Use Disorder clinical trials — from first-in-human safety studies through Phase IV post-market research.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our research sites support medication-assisted treatment studies, behavioral therapy evaluations, relapse prevention programs, and neuroscience-focused addiction research initiatives.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog